Serum fibroblast growth factor-2 levels complement vital biomarkers for diagnosing heart failure

Serum fibroblast growth factor-2 levels complement vital biomarkers for diagnosing heart failure

Abstract Background Early diagnosis of atrial fibrillation is important as it is crucial for improving patient outcomes. Fibroblast growth factor-2 (FGF2) may serve as a diagnostic biomarker for heart failure due to its ability to promote cardiac fibrosis and hypertrophy; however, the relationship b...

Full description

Bibliographic Details
Main Authors: Z. L. Yu, Z. H. Cai, J. T. Zheng, H. Y. Jiang, Y. Q. Zhou, N. K. Wong, H. B. Fu, X. B. Hong
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Cardiovascular Disorders
Subjects:
Biomarker
Left ventricular ejection fraction
Fibroblast growth factor-2
Heart failure
Cardiac hypertrophy
Online Access:https://doi.org/10.1186/s12872-024-03768-4

Internet

https://doi.org/10.1186/s12872-024-03768-4

Similar Items